| Meloxicam |
20020142 |
MOVALIS, Solution for injection, 15 mg/1,5 ml, mg, Pack: 5 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Espana SA, Spain |
4.34 |
0.87 |
5.21 |
7% |
0.3 |
4.64 |
0.93 |
5.57 |
20% |
0.87 |
5.51 |
1.1 |
6.61 |
корекц. НСР-8182/22.02.2016, промяна на обстоятелства НСР-9764/14.07.2016 |
НСР-7809/28.12.2015; НСР-14303/26.10.2017 |
12.02.2017 |
02.12.2017 |
Заличен |
2237 |
| Meloxicam |
20020142 |
MOVALIS, Solution for injection, 15 mg/1,5 ml, mg, Pack: 5 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Espana SA, Spain |
4.34 |
0.87 |
5.21 |
7% |
0.3 |
4.64 |
0.93 |
5.57 |
20% |
0.87 |
5.51 |
1.1 |
6.61 |
корекц. НСР-8182/22.02.2016, промяна на обстоятелства НСР-9764/14.07.2016 |
НСР-7809/28.12.2015 |
13.01.2016 |
02.08.2016 |
Неактивен |
2237 |
| Meloxicam |
20020142 |
MOVALIS, Solution for injection, 15 mg/1,5 ml, mg, Pack: 5 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Espana SA, Spain |
4.34 |
0.87 |
5.21 |
7% |
0.3 |
4.64 |
0.93 |
5.57 |
20% |
0.87 |
5.51 |
1.1 |
6.61 |
корекц. НСР-8182/22.02.2016; промяна на обстоятелства НСР-9764/14.07.2016 |
НСР-7809/28.12.2015 |
13.01.2016 |
13.01.2016 |
Неактивен |
2237 |
| Meloxicam |
II-0305/ 27.07.2007 |
MOVALIS, Solution for injection, 15 mg/1,5 ml, mg, Pack: 5 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Espana SA, Spain |
4.34 |
0.87 |
5.21 |
7% |
0.3 |
4.64 |
0.93 |
5.57 |
20% |
0.87 |
5.51 |
1.1 |
6.61 |
корекц. НСР-8182/22.02.2016 |
НСР-7809/28.12.2015 |
13.01.2016 |
13.01.2016 |
Неактивен |
2237 |
| Meloxicam |
II-0305/ 27.07.2007 |
MOVALIS, Solution for injection, 15 mg/1,5 ml, mg, Pack: 5 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Espana SA, Spain |
4.44 |
0.89 |
5.33 |
7% |
0.31 |
4.75 |
0.95 |
5.7 |
20% |
0.89 |
5.64 |
1.13 |
6.77 |
|
НСР-1611/01.11.2013 |
19.11.2013 |
19.11.2013 |
Неактивен |
2237 |
| Meloxicam |
II-0305/ 27.07.2007 |
MOVALIS, Solution for injection, 15 mg/1,5 ml, mg, Pack: 5 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Espana SA, Spain |
4.5 |
0.9 |
5.4 |
7% |
0.32 |
4.82 |
0.96 |
5.78 |
20% |
0.9 |
5.72 |
1.14 |
6.86 |
|
КЦРР-1122/02.08.2012 |
17.08.2012 |
17.08.2012 |
Неактивен |
2237 |
| Meloxicam |
II-0305/27.07.2007 г. |
MOVALIS, Solution for injection, 15 mg/1,5 ml, mg, Pack: 5 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Espana SA, Spain |
6.34 |
1.27 |
7.61 |
9% |
0.57 |
6.91 |
1.38 |
8.29 |
22% |
1.39 |
8.3 |
1.66 |
9.96 |
|
КЦ-585/23.02.2009 |
18.03.2009 |
18.03.2009 |
Неактивен |
2237 |
| Meloxicam |
II-16206/ 06.04.2007 |
MOVALIS, Tablet, 7,5 mg, mg, Pack: 20 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Hellas S.A.Athens- Greece; Boehringer Ingelheim Pharma GmbH & Co.KG, Germany |
2.56 |
0.51 |
3.07 |
7% |
0.18 |
2.74 |
0.55 |
3.29 |
20% |
0.51 |
3.25 |
0.65 |
3.9 |
цената е заличена с решение НСР-8308/26.02.2016 (в сила от 02.04.2016 година) |
НСР-7810/28.12.2015 |
13.01.2016 |
13.01.2016 |
Заличен |
2236 |
| Meloxicam |
II-16206/ 06.04.2007 |
MOVALIS, Tablet, 7,5 mg, mg, Pack: 20 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Hellas S.A.Athens- Greece; Boehringer Ingelheim Pharma GmbH & Co.KG, Germany |
3.15 |
0.63 |
3.78 |
7% |
0.22 |
3.37 |
0.67 |
4.04 |
20% |
0.63 |
4 |
0.8 |
4.8 |
|
НСР-1613/01.11.2013 |
19.11.2013 |
19.11.2013 |
Неактивен |
2236 |
| Meloxicam |
II-16206/ 06.04.2007 |
MOVALIS, Tablet, 7,5 mg, mg, Pack: 20 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Hellas S.A.Athens- Greece; Boehringer Ingelheim Pharma GmbH & Co.KG, Germany |
3.5 |
0.7 |
4.2 |
7% |
0.25 |
3.75 |
0.75 |
4.5 |
20% |
0.7 |
4.45 |
0.89 |
5.34 |
|
КЦРР-1122/02.08.2012 |
17.08.2012 |
17.08.2012 |
Неактивен |
2236 |
| Meloxicam |
II-16206/06.04.2007 г. |
MOVALIS, Tablet, 7,5 mg, mg, Pack: 20 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Hellas S.A.Athens- Greece; Boehringer Ingelheim Pharma GmbH & Co.KG, Germany |
8.43 |
1.69 |
10.12 |
9% |
0.76 |
9.19 |
1.84 |
11.03 |
22% |
1.85 |
11.04 |
2.21 |
13.25 |
|
КЦ-585/23.02.2009 |
18.03.2009 |
18.03.2009 |
Неактивен |
2236 |
| Meloxicam |
9600238 |
MOVALIS, Tablet, 15, mg, Pack: 10 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Ellas A. E., Гърция; Boehringer Ingelheim Pharma GmbH & Co.KG, Germany |
2.29 |
0.46 |
2.75 |
7% |
0.16 |
2.45 |
0.49 |
2.94 |
20% |
0.46 |
2.91 |
0.58 |
3.49 |
|
КЦРР-2642/20.03.2013; НСР-9513/09.06.2016 |
02.07.2016 |
02.07.2016 |
Заличен |
1825 |
| Meloxicam |
II-16207/06.04.2007 г. |
MOVALIS, Tablet, 15 mg, mg, Pack: 10 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Hellas S.A.Athens; Boehringer Ingelheim Pharma GmbH & Co.KG, Germany |
2.29 |
0.46 |
2.75 |
7% |
0.16 |
2.45 |
0.49 |
2.94 |
20% |
0.46 |
2.91 |
0.58 |
3.49 |
|
КЦРР-2642/20.03.2013 |
24.04.2013 |
24.04.2013 |
Неактивен |
1825 |
| Meloxicam |
II-16207/06.04.2007 г. |
MOVALIS, Tablet, 15 mg, mg, Pack: 10 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Hellas S.A.Athens; Boehringer Ingelheim Pharma GmbH & Co.KG, Germany |
3.27 |
0.65 |
3.92 |
7% |
0.23 |
3.5 |
0.7 |
4.2 |
20% |
0.65 |
4.15 |
0.83 |
4.98 |
|
КЦ-304/28.11.2008 |
25.12.2008 |
25.12.2008 |
Неактивен |
1825 |
| Meloxicam |
20110702 |
Movix, Solution for injection, 15 mg/1,5 ml, mg, Pack: 10 |
Софарма АД, България |
Софарма АД, България |
11 |
2.2 |
13.2 |
6% |
0.66 |
11.66 |
2.33 |
13.99 |
18% |
1.98 |
13.64 |
2.73 |
16.37 |
|
КЦРР-1617/05.11.2012; НСР-12075/21.03.2017 |
21.11.2012 |
02.05.2017 |
Заличен |
1440 |
| Meloxicam |
20110702 |
Movix, Solution for injection, 15 mg/1,5 ml, mg, Pack: 10 |
Софарма АД, България |
Софарма АД, България |
11 |
2.2 |
13.2 |
6% |
0.66 |
11.66 |
2.33 |
13.99 |
18% |
1.98 |
13.64 |
2.73 |
16.37 |
|
КЦРР-1617/05.11.2012 |
21.11.2012 |
21.11.2012 |
Неактивен |
1440 |
| Meloxicam |
20110702 |
Movix, Solution for injection, 15 mg/1,5 ml, mg, Pack: 10 |
Софарма АД, България |
|
11 |
2.2 |
13.2 |
6% |
0.66 |
11.66 |
2.33 |
13.99 |
18% |
1.98 |
13.64 |
2.73 |
16.37 |
|
КЦРР-1617/05.11.2012 |
21.11.2012 |
21.11.2012 |
Неактивен |
1440 |
| Teriparatide |
EU/1/16/1161/002 |
Movymia, Solution for injection, 20 mcg/80 mcl - 2.4 ml (28 doses), mg, Pack: 3 cartridges |
Stada Arzneimittel AG, Германия |
Gedeon Richter Plc., Унгария |
1094.29 |
218.86 |
1313.15 |
4% |
10 |
1104.29 |
220.86 |
1325.15 |
16% |
25 |
1129.29 |
225.86 |
1355.15 |
|
НСР-20124/08.11.2019; НСР-21012/13.03.2020 предварително изпълнение |
23.11.2019 |
02.04.2020 |
Заличен |
16769 |
| Teriparatide |
EU/1/16/1161/002 |
Movymia, Solution for injection, 20 mcg/80 mcl - 2.4 ml (28 doses), mg, Pack: 3 cartridges |
Stada Arzneimittel AG, Германия |
Gedeon Richter Plc., Унгария |
1094.29 |
218.86 |
1313.15 |
4% |
10 |
1104.29 |
220.86 |
1325.15 |
16% |
25 |
1129.29 |
225.86 |
1355.15 |
|
НСР-20124/08.11.2019 |
23.11.2019 |
02.12.2019 |
Неактивен |
16769 |
| Teriparatide |
EU/1/16/1161/002 |
Movymia, Solution for injection, 20 mcg/80 mcl - 2.4 ml (28 doses), mg, Pack: 3 cartridges |
Stada Arzneimittel AG, Германия |
Gedeon Richter Plc., Унгария |
1094.29 |
218.86 |
1313.15 |
4% |
10 |
1104.29 |
220.86 |
1325.15 |
16% |
25 |
1129.29 |
225.86 |
1355.15 |
|
НСР-20124/08.11.2019 |
23.11.2019 |
02.12.2019 |
Неактивен |
16769 |
| Teriparatide |
EU/1/16/1161/003 |
Movymia, Solution for injection, 20 mcg/80 mcl - 2.4 ml (28 doses), mg, Pack: 1 cartridge + 1 pen |
Stada Arzneimittel AG, Германия |
Gedeon Richter Plc., Унгария |
364.76 |
72.95 |
437.71 |
4% |
10 |
374.76 |
74.95 |
449.71 |
16% |
25 |
399.76 |
79.95 |
479.71 |
|
НСР-20124/08.11.2019; НСР-21012/13.03.2020 предварително изпълнение |
23.11.2019 |
02.04.2020 |
Заличен |
16765 |
| Teriparatide |
EU/1/16/1161/003 |
Movymia, Solution for injection, 20 mcg/80 mcl - 2.4 ml (28 doses), mg, Pack: 1 cartridge + 1 pen |
Stada Arzneimittel AG, Германия |
Gedeon Richter Plc., Унгария |
364.76 |
72.95 |
437.71 |
4% |
10 |
374.76 |
74.95 |
449.71 |
16% |
25 |
399.76 |
79.95 |
479.71 |
|
НСР-20124/08.11.2019 |
23.11.2019 |
02.03.2020 |
Неактивен |
16765 |
| Teriparatide |
EU/1/16/1161/003 |
Movymia, Solution for injection, 20 mcg/80 mcl - 2.4 ml (28 doses), mg, Pack: 1 cartridge + 1 pen |
Stada Arzneimittel AG, Германия |
Gedeon Richter Plc., Унгария |
364.76 |
72.95 |
437.71 |
4% |
10 |
374.76 |
74.95 |
449.71 |
16% |
25 |
399.76 |
79.95 |
479.71 |
|
НСР-20124/08.11.2019 |
23.11.2018 |
02.12.2019 |
Неактивен |
16765 |
| Teriparatide |
EU/1/16/1161/003 |
Movymia, Solution for injection, 20 mcg/80 mcl - 2.4 ml (28 doses), mg, Pack: 1 cartridge + 1 pen |
Stada Arzneimittel AG, Германия |
Gedeon Richter Plc., Унгария |
364.76 |
72.95 |
437.71 |
4% |
10 |
374.76 |
74.95 |
449.71 |
16% |
25 |
399.76 |
79.95 |
479.71 |
|
НСР-20124/08.11.2019 |
23.11.2018 |
02.12.2019 |
Неактивен |
16765 |
| Teriparatide |
EU/1/16/1161/001 |
Movymia, Solution for injection, 20 mcg/80 mcl - 2.4 ml (28 doses), mg, Pack: 1 cartridge |
Stada Arzneimittel AG, Германия |
Gedeon Richter Plc., Унгария |
322.71 |
64.54 |
387.25 |
4% |
10 |
332.71 |
66.54 |
399.25 |
16% |
25 |
357.71 |
71.54 |
429.25 |
|
НСР-20124/08.11.2019; НСР-21012/13.03.2020 предварително изпълнение |
23.11.2019 |
02.04.2020 |
Заличен |
16767 |